Your browser doesn't support javascript.
loading
Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing-remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis.
Lees, Samuel; Dicker, Mathew; Ku, Jie En; Chaganti, Varun; Mew-Sum, Matthew; Wang, Nick; Smith, Angela; Oldmeadow, Christopher; Goon, Wooi Lynn; Bevan, Marc; Lang, Danielle; Hinwood, Madeleine.
Afiliação
  • Lees S; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Dicker M; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Ku JE; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Chaganti V; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Mew-Sum M; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Wang N; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Smith A; HNEHealth Libraries, Hunter New England Local Health District, New Lambton, New South Wales, Australia.
  • Oldmeadow C; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Goon WL; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Bevan M; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Lang D; School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia.
  • Hinwood M; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
BMJ Open ; 11(11): e051509, 2021 11 02.
Article em En | MEDLINE | ID: mdl-34728450

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália